Drugs / allogeneic γδ T cell infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07237230 | Jul 2025 → Jul 2028 expected | acute myeloid leukemia | Donghua Zhang | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | allogeneic γδ T cell infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07237230 ↗ |
| Modality | Cell therapy | “allogeneic γδ T cell infusion” NCT07237230 ↗ |